A recent article co-authored by The New York Times’ Apoorva Mandavilli and Katie Thomas asks a question most Americans want to be answered: “Will an Antibody Test Allow Us to Go Back to School or Work?”
The leading infectious disease expert in the country, Dr. Anthony Fauci, told CNN last Friday, “Within a period of a week or so, we are going to have a rather large number of tests that are available.”
On March 26, Vice President Mike Pence announced that Abbott Laboratories had developed such a point-of-care test, “meaning that from the time to swab, to the time you get a positive result: five minutes. Like the President said, and at most, 15 minutes for a negative result…think of it as a 15-minute test.”
On April 11, Admiral Brett P. Giroir, the Assistant Secretary for Health at the U.S. Department of Health and Human Services (HHS) estimated those tests “would be available in the course of weeks.”
President Trump has done much to undo years of overregulation. The FDA needs it. To date, there have been 90 viable point-of-care tests submitted to the FDA and only 3 have been approved. The FDA’s hesitance to approve much-needed testing proves there is much yet to be done.
Watch the video as Candace Owens asks the right questions and reveals what we should do while we wait for those answers.
